Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic
Clinical trial NCT01091662 · COMPLETED
Trial details
- NCT number
- NCT01091662
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-11-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.